Broadfin Healthcare Master Fund Ltd, 10% Owner at Recro Pharma, Inc. (REPH), sold 48,566 shares at $9.37 ($455K) on 2017-11-22, disclosed to the SEC on 2017-11-24.
Open-market sale of $455k REPH by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| Filing → |
| REPH | SELL | 2017-12-14 | $1.5M | — | Filing → |
| REPH | SELL | 2017-12-07 | $1.0M | — | Filing → |
| PETX | SELL | 2017-12-01 | $5.1M | — | Filing → |